MicroRNAs in prostate cancer: Functional role as biomarkers

Research output: Contribution to journalReview articlepeer-review

136 Scopus citations

Abstract

MicroRNAs (miRNAs) are small endogenous non-coding molecules that alters gene expression through post-transcriptional regulation of messenger RNA. Compelling evidence suggest the role of miRNA in cancer biology having potential as diagnostic, prognostic and predictive biomarkers. This review summarizes the current knowledge on miRNA deregulated in prostate cancer and their role as oncogene, tumor suppressor and metastasis regulators. The emerging information elucidating the biological function of miRNA is promising and may lead to their potential usefulness as diagnostic/prognostic markers and development as effective therapeutic tools for management of prostate cancer.
Original languageEnglish
Pages (from-to)9-20
Number of pages12
JournalCancer Letters
Volume407
DOIs
StatePublished - Oct 28 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Androgen receptor
  • Biomarkers
  • Castrate-resistant prostate cancer
  • Non-coding RNA
  • Oncomirs
  • Tumor suppressor

Cite this